Author

Ali Taş

Leiden UniversityORCID 0009-0001-1497-766XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Eric J. SnijderiD· 2 shared A. Spruit· 1 shared Anja W. M. de JongiD· 1 shared Anton Jan van ZonneveldiD· 1 shared Eric P. van der VeeriD· 1 shared Falk WachowiusiD· 1 shared Maria SoultsiotiiD· 1 shared Martijn J. van HemertiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Eric J. SnijderORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of VirologyPeer-reviewedFeb 20, 2025

Perturbation of de novo lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles

Maria Soultsioti, Anja W. M. de Jong, Nienke J. Blomberg…·Montserrat Bárcena

This study shows that inhibiting ACC disrupts MERS-CoV particle release but not replication organelle formation, highlighting ACC as a potential antiviral target.

11 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintNov 28, 2022

Highly potent antisense oligonucleotides (ASOs) targeting the SARS-CoV-2 RNA genome

Vita Dauksaite, Ali Taş, Falk Wachowius…·Anton Jan van Zonneveld

ASOs (LNA gapmers) targeting the SARS-CoV-2 RNA genome effectively reduce viral RNA load by up to 96% in vitro.

1 citation

humanexperimental assay

𝕏 PostBluesky